Bio-AMD, Inc. ($BIAD) $0.25 Bio-AMD, Inc., a
Post# of 579
Posted On: 03/16/2015 10:28:33 AM
Bio-AMD, Inc. ($BIAD) $0.25
Bio-AMD, Inc., a development stage company, through its subsidiary, Bio AMD Holdings Limited, focuses on developing hand held electronic medical diagnostic devices. It offers point of care (POC) medical diagnostic products, including a disposable micro-fluidic test strip to measure prothrombin time/international normalized ratio through a POC blood coagulation monitoring device that enables patient based, anticoagulant drug therapy monitoring; and a digital strip reader to read various lateral flow based immunoassay diagnostic test strips in the areas of cardiac markers, infectious diseases, drugs of abuse, and female wellbeing. The company also provides disposable test strip combining micro-fluidics and lab-on-chip technology, which offers quantitative measurement into a immunoassay platform that detects nanoparticles through magnetic manipulation. In addition, Bio-AMD, Inc., through its subsidiary, WOCU Limited, develops WOCU, a foreign exchange derivative quotation to mitigate currency risk that would be licensed into various corporate and retail financial products, including exchange traded funds, indexed structured products, and derivatives.
http://www.bioamd.com/
Bio-AMD, Inc., a development stage company, through its subsidiary, Bio AMD Holdings Limited, focuses on developing hand held electronic medical diagnostic devices. It offers point of care (POC) medical diagnostic products, including a disposable micro-fluidic test strip to measure prothrombin time/international normalized ratio through a POC blood coagulation monitoring device that enables patient based, anticoagulant drug therapy monitoring; and a digital strip reader to read various lateral flow based immunoassay diagnostic test strips in the areas of cardiac markers, infectious diseases, drugs of abuse, and female wellbeing. The company also provides disposable test strip combining micro-fluidics and lab-on-chip technology, which offers quantitative measurement into a immunoassay platform that detects nanoparticles through magnetic manipulation. In addition, Bio-AMD, Inc., through its subsidiary, WOCU Limited, develops WOCU, a foreign exchange derivative quotation to mitigate currency risk that would be licensed into various corporate and retail financial products, including exchange traded funds, indexed structured products, and derivatives.
http://www.bioamd.com/
(0)
(0)